Drug Database
YY

YY-3130 (YY 3130 / YY3130)

✓ Approved

YuYu Pharma · 小分子 · 小分子

什么是 YY-3130?

YY-3130 是一种小分子,由YuYu Pharma研发。该药已获批,用于治疗相关适应症,给药途径:Unknown。

药物档案

商品名YY 3130, YY3130
公司YuYu Pharma
药物类别小分子
给药途径Unknown
状态Approved

治疗适应症

YY-3130 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Metabolism and nutrition disordersHypercholesterolaemia✓ Approved

相关研究文献

PubMedJournal of colloid and interface science2026-11-18

Surface-engineered lyotropic liquid crystal nanoparticles via layer-by-layer self-assembly of carboxymethyl starch and whey protein isolate for colon-targeted delivery of bioactive lipid and stimulation of satiety hormones secretion.

Su Haize H, Huang Shuangxia S, Li Yingying Y, Zhang Zhibing Z et al.

Stimulating satiety hormones glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) secretion through nutritional components is a potential strategy for appetite management. We hypothesized that combining a pH-responsive lyotropic liquid crystal (LLC) core with a layer-by-layer assembled biopolymer interface could balance colloidal stability during upper gastrointestinal digestion with subsequent disassembly and oleoylethanolamide (OEA) release. OEA-containing LLC (OLLC) nanoparticles were coated with one or two denatured whey protein isolate/carboxymethyl starch bilayers, followed by tannic acid reinforcement. Structural characterization, stability measurements, and simulated digestion were performed to relate internal organization and interfacial assembly to apparent OEA release, while separate fecal fermentation and cell assays assessed downstream functionality. The OLLC nanoparticles exhibited pH-dependent inverse hexagonal (H2) and bicontinuous cubic (Im3m) organization. Nanoparticles bearing one bilayer (OLLC-1TA) achieved an OEA encapsulation efficiency of 95.67 ± 0.71%, with apparent release of 15.58 ± 0.15% during simulated upper gastrointestinal digestion and 84.42 ± 2.77% in the simulated colonic stage. Adding a second bilayer increased aggregation and restricted subsequent release, with little numerical improvement in limiting upper gastrointestinal release. These findings indicate that increasing the extent of interfacial assembly does not necessarily improve delivery performance. Notably, fermentation products of OLLC-1TA stimulated GLP-1 and PYY secretion in vitro, increasing their levels by 316.15% and 436.19%, respectively, relative to the blank group. Overall, the results identify a balance between interfacial stabilization and digestive disassembly as a design principle for these liquid crystal carriers and support further investigation of their potential for colon-directed delivery.

PMID 43051079
阅读全文 →
PubMedFrontiers in microbiology2026-11-18

Dietary betaine supplementation modulates feed intake via the microbiota-gut-brain axis in finishing pigs fed low-energy diets.

Liang Chan C, Fu Runqi R, Gu Zhemin Z, Pu Junning J et al.

Betaine (BET), a key metabolic intermediate, regulates energy metabolism and influences feed intake, yet its mechanism remains unclear. This study investigated whether BET modulates feed intake in finishing pigs via the microbiota-gut-brain axis under varying dietary net energy (NE) levels. Seventy-two pigs (82.63 ± 4.13 kg) were allotted to six treatments in a 2 × 3 factorial arrangement, including two BET levels (0 or 1,500 mg/kg) and three NE levels (2,555, 2,475, or 2,395 kcal/kg). Results showed that, in pigs fed low-NE diets, dietary BET significantly reduced average weekly feed intake (AWFI) during week 6 (p < 0.05). Across the entire 42-day period, average daily feed intake (ADFI) was numerically reduced by 6.05%, although this difference was not significant (p > 0.05), whereas no such effect occurred in pigs fed normal- or high-NE diets (p > 0.05). The addition of BET to low-NE diets resulted in elevated serum levels of cholecystokinin (CCK) and peptide YY (PYY), as well as a decrease in orexigenic neuropeptides (AgRP) and an increase in anorexigenic neuropeptides (POMC) within the hypothalamus (p < 0.05), indicating appetite suppression. Furthermore, BET was found to upregulate hypothalamic G protein-coupled receptor 41 (GPR41) and GPR43 mRNA expression in pigs on low-NE diets (p < 0.01). This effect was accompanied by increased volatile fatty acid (VFA) levels in both serum and hindgut digesta (p < 0.05), driven by BET-induced alterations in gut microbial composition. Notably, these compositional changes consisted of a reduction in the abundance of Prevotella and an increase in the populations of NK4A214_group and Methanobrevibacter (p < 0.05). Collectively, these findings support the involvement of the microbiota-gut-brain axis in the feed-intake response to BET under low-NE conditions and provide a mechanistic basis for further evaluating BET as a nutritional strategy to improve feed-energy utilization.

PMID 43047525
阅读全文 →
PubMedPsychiatry2026-11-16

Genetic Evidence Linking Gut-Brain Peptide Signaling to Anorexia Nervosa: Implications for Early Risk Detection.

Zeng Xin X, Chen Jie J, Fu Yansong Y, Yang Keyi K et al.

Anorexia nervosa (AN) is a severe psychiatric disorder with high mortality, yet its biological underpinnings remain unclear. Gut-brain peptides, which influence brain function through circulatory and vagal routes, have emerged as potential contributors to AN, though causal relationships remain unexplored. Given the unclear biological mechanisms and lack of biomarkers for AN, this study aims to explore the causal role of gut-brain peptides in AN development, in order to identify potential diagnostic or therapeutic targets. We applied Mendelian randomization (MR) to assess the causal effects of 12 gut-brain peptides on AN risk, using genome-wide association study (GWAS) data from populations of European ancestry. The inverse variance weighted (IVW) method was the primary analytic tool, supplemented with sensitivity analyses. Peptides showing associations with AN were also tested across five other psychiatric disorders: schizophrenia (SCZ), major depressive disorder (MDD), bipolar disorder (BD), autism spectrum disorder (ASD), and attention-deficit/hyperactivity disorder (ADHD)-were also explored. Elevated peptide YY (PYY) levels were causally linked to increased AN risk (OR = 1.07, 95% CI: 1.01-1.15, p = .035). No significant associations were found for the other peptides. Reverse MR showed that genetic liability to AN was associated with reduced levels of leptin and chromogranin A (CgA). These associations were not observed in the five other psychiatric disorders. This study identifies PYY as a potential causal factor in AN and highlights leptin and CgA as downstream biomarkers. These findings suggest gut-brain peptides may be uniquely involved in AN pathogenesis, offering targets for early detection and therapeutic intervention.

PMID 43037360
阅读全文 →
PubMedAnimals : an open access journal from MDPI2026-11-14

Indole-3-Lactic Acid Modulates Feeding Behavior and Appetite-Related Signals in Weaned Piglets.

Chen Keyi K, Dong Xinghua X, He Huixuan H, Huang Yu Y et al.

Gut microbiota-derived metabolites act as important mediators linking the gut microbiome with host physiological functions and participate in the regulation of metabolic homeostasis and behavior. However, whether the tryptophan metabolite indole-3-lactic acid (ILA) regulates feeding behavior in piglets and its potential central regulatory mechanisms remain unclear. In this study, 12 weaned piglets were used as a model to investigate the effects of ILA on feeding behavior regulation. The results showed that ILA supplementation did not significantly affect growth performance (p > 0.05), although final body weight, average daily gain, and average daily feed intake were numerically higher in the ILA group than in the control group. ILA also altered feeding behavior patterns, characterized by reduced daily feeding frequency (p < 0.05) and increased feeding rate (p = 0.053). Furthermore, ILA significantly increased serum concentrations of several appetite-related gastrointestinal hormones, including glucagon-like peptide-1, peptide YY, ghrelin, and cholecystokinin, and modified serum lipid metabolism-related parameters (p < 0.05). Hypothalamic transcriptomic analysis identified 240 differentially expressed genes in the ILA group compared with the CON group, with enrichment of genes involved in neural signaling and appetite regulation. These findings suggest that ILA may influence feeding behavior in weaned piglets, accompanied by numerical increases in feed intake and growth-related parameters, as well as changes in peripheral appetite-related gastrointestinal hormones and hypothalamic transcriptional responses.

PMID 43027115
阅读全文 →
PubMedCatalysis science & technology2026-11-11

Highly active earth-abundant ammonia cracking catalysts using long chain hydrocarbon stabilised colloidal nanoparticles.

Mahin Julien J, El-Kadi Joseph J, Torrente-Murciano Laura L

In this work, we report the synthesis of highly active non-noble metal catalysts with controlled nanoparticle size and dispersion through a new catalyst preparation strategy, combining the continuous-flow synthesis of size-controlled Fe, Co and Ni nanoparticles by thermal decomposition of zero-valent precursors with their direct impregnation via the so-called colloidal incipient wetness impregnation (CIWI). The use of long-chain hydrocarbon ligands provides not only size control and colloidal stability at high nanoparticle concentration but also the synergetic simultaneous removal and metal reduction at low temperatures. Indeed, we demonstrate that the removal of these ligands is catalysed by Co and Ni particles, enabling their simultaneous reduction at lower temperatures and thus, avoiding their agglomeration. This combination of controlled nanoparticle synthesis, high-concentration processing and in situ self-cleaning provides a route to size control that is difficult to access by conventional incipient wetness impregnation. The flexibility of CIWI further enables systematic investigation of nanoparticle size-activity relationships independently of support effects. Applied to ammonia decomposition, Ni/CeO2 exhibits a pronounced size dependence, with 2.4 nm Ni nanoparticles delivering an activity of 3130 molNH3 molmetal -1 s-1 at 500 °C, ranking among the most active earth-abundant catalysts reported to date and approaching the performance of state-of-the-art Ru-based systems. The CIWI therefore provides a versatile platform for designing highly active, size-controlled non-noble metal catalysts and is broadly applicable to other metal-support combinations and catalytic reactions.

PMID 43011919
阅读全文 →
PubMedFrontiers in medicine2026-11-08

Enteroendocrine signaling in irritable bowel syndrome: beyond cell counts toward stimulus-responsive physiological profiling.

Han Jiayi J, Lang Yixuan Y, Yao Kangmeng K, Mi Jia J

Meals are a major symptom trigger in irritable bowel syndrome (IBS), yet the endocrine steps linking luminal nutrients to pain, bloating, urgency, and altered bowel habits remain poorly defined. Early studies relied heavily on mucosal enteroendocrine cell (EEC) counts. Those observations remain informative, particularly in post-infectious IBS, but findings vary with intestinal site, bowel-habit phenotype, staining, and morphometry, and cell abundance does not measure secretory function. Human meal-challenge studies distinguish circulating concentrations from stimulus-evoked responses. In IBS with diarrhea, higher fasting and fed plasma 5-hydroxytryptamine (serotonin, 5-HT) may reflect altered handling more than a uniformly exaggerated postprandial response, whereas IBS with constipation can show impaired stimulus-evoked release. Cholecystokinin, peptide YY, motilin, ghrelin, and related peptides also vary with sex, bowel habit, and visceral sensitivity. Recent human organoid and transcriptomic studies identify distinct nutrient-sensing programs among EEC subtypes and provide a cellular framework for this heterogeneity. We integrate these findings across luminal sensing, secretion, metabolism, receptor responsiveness, and motor or sensory output. The evidence does not support a single IBS endocrine signature. Standardized nutrient challenges linked to serial hormone measurements, mucosal molecular data, and objective physiological readouts are more likely to yield reproducible and clinically testable response patterns.

PMID 42996977
阅读全文 →

注册免费账户还可查看另外 4533 篇文献

免费注册查看全部文献 →

了解更多YY-3130